glp-1 drugs and parkinson's disease A Big Week for - by Eric Topol GLP-1a: Going beyond Traditional Use

He shopped his idea around at the Department of Veterans Affairs, where he worked at the time, as well as several different pharmaceutical companies, but didn't have much success

The medication hasnt completed the clinical drug trial process yet and thus isnt approved by the FDA

Phentermine efficacy ceiling of 5 to 10 percent body weight loss is insufficient for someone who needs to lose 30 percent or more

Follow up PET examinations were performed after 17 (GCGR) and 20 (GLP-1R) days of treatment with SAR425899, to assess the occupancy at each receptor

doi:10.4254/wjh.v14.i1.45 15

Clinical trials report excellent tolerability